Dr. Daniela Cipolletta is Senior Director of Immunology at Seismic Therapeutic, developing a new generation of immunology therapies enabled by machine learning. Daniela has 20 years of immunology-focused research experience, with an emphasis on bridging immunology with oncology, metabolism, and tissue regeneration. Before joining Seismic, she held roles of increasing responsibility at Novartis, where she led and supported several novel immune modulatory programs from early target identification through drug candidate selection and biomarker research. Daniela has also held positions at Amgen and Tempero (a GSK company).
Daniela earned her PhD in Immunology from the European School of Molecular Medicine and completed her postdoctoral training with Drs. Diane Mathis and Christophe Benoist at Harvard Medical School, working on tissue-resident regulatory T cells.